ecteinascidin 743 has been researched along with Chromosomal Translocation in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alfaro, V; Blay, JY; Chawla, SP; Hendifar, A; Hohenberger, P; Lardelli, P; Leahy, MG; Nguyen, BB; Nieto, A; Patel, SR; Penel, N; Piperno-Neumann, S; Santoro, A; Staddon, AP | 1 |
| Allavena, P; Badri, N; D'Incalci, M; Galmarini, CM | 1 |
| Le Cesne, A; Reichardt, P | 1 |
| Araki, N; Hiraga, H; Hiruma, T; Kawai, A; Kunisada, T; Matsumine, A; Morioka, H; Sugiura, H; Takahashi, M; Takahashi, S; Ueda, T; Yonemoto, T | 1 |
| Asanuma, H; Hasegawa, T; Sugita, S | 1 |
| Alfaro, V; Balaña, C; Blay, JY; Casali, PG; Cresta, S; Demetri, GD; Grosso, F; Lardelli, P; Le Cesne, A; Maki, RG; Nieto, A; Poveda, A; Schöffski, P; Verweij, J | 1 |
2 review(s) available for ecteinascidin 743 and Chromosomal Translocation
| Article | Year |
|---|---|
Trabectedin, a drug acting on both cancer cells and the tumour microenvironment.
Topics: Animals; Antineoplastic Agents, Alkylating; Dioxoles; Humans; Liposarcoma, Myxoid; Tetrahydroisoquinolines; Trabectedin; Translocation, Genetic; Tumor Microenvironment | 2014 |
Optimizing the use of trabectedin for advanced soft tissue sarcoma in daily clinical practice.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Chemical and Drug Induced Liver Injury; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dioxoles; Disease Progression; Drug Administration Schedule; Hematologic Diseases; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Middle Aged; Multicenter Studies as Topic; Palliative Care; Patient Selection; Randomized Controlled Trials as Topic; Salvage Therapy; Sarcoma; Soft Tissue Neoplasms; Tetrahydroisoquinolines; Trabectedin; Translocation, Genetic | 2015 |
2 trial(s) available for ecteinascidin 743 and Chromosomal Translocation
| Article | Year |
|---|---|
Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Dioxoles; Doxorubicin; Drug Administration Schedule; Fatigue; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Leukopenia; Male; Middle Aged; Nausea; Sarcoma; Tetrahydroisoquinolines; Trabectedin; Translocation, Genetic; Treatment Outcome; Young Adult | 2014 |
Diagnostic use of fluorescence in situ hybridization in expert review in a phase 2 study of trabectedin monotherapy in patients with advanced, translocation-related sarcoma.
Topics: Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Dioxoles; Genetic Predisposition to Disease; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Japan; Phenotype; Predictive Value of Tests; Sarcoma; Tetrahydroisoquinolines; Time Factors; Trabectedin; Translocation, Genetic; Treatment Outcome | 2016 |
2 other study(ies) available for ecteinascidin 743 and Chromosomal Translocation
| Article | Year |
|---|---|
Retrospective inter- and intra-patient evaluation of trabectedin after best supportive care for patients with advanced translocation-related sarcoma after failure of standard chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Clinical Trials, Phase II as Topic; Cross-Over Studies; Dioxoles; Disease Progression; Disease-Free Survival; Drug Substitution; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Palliative Care; Randomized Controlled Trials as Topic; Retrospective Studies; Sarcoma; Tetrahydroisoquinolines; Time Factors; Trabectedin; Translocation, Genetic; Treatment Failure; Young Adult | 2016 |
A retrospective analysis of antitumour activity with trabectedin in translocation-related sarcomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Clinical Trials, Phase II as Topic; Dioxoles; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Retrospective Studies; Sarcoma; Tetrahydroisoquinolines; Time Factors; Trabectedin; Translocation, Genetic; Treatment Outcome; Young Adult | 2012 |